Ehealth earnings date
Ehealth (M5V) Q3 2026 Earnings Report
DE:M5V Q3 2026 EPS Results
- Actual EPS
- -EUR 1.30
- Consensus EPS
- -EUR 0.98
- Beat/Miss
- Missed by -EUR 0.32
- One Year Ago EPS
- -EUR 1.13
DE:M5V Q3 2026 Revenue Results
- Actual Revenue
- EUR 19.05M
- Expected Revenue
- EUR 23.66M
- Beat/Miss
- Missed by -EUR 4.61M
- YoY Revenue Growth
- -60.49%
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 11/04/2026
- Time
- After Close
- Conference Call
- Wednesday, November 4, 2026
Ehealth's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
Q3 2026 Earnings Slide Deck
Q3 2026 Earnings Call Summary
The call presented a mixed picture. Management highlighted substantial cost reductions, sharply improved year-to-date cash flow, favorable early AEP demand, early retention and ancillary cross-sell gains from the Lifetime Advisory Model, new carrier and distribution partnerships, and reaffirmed guidance. However, current-quarter financial performance remained weak, with significant declines in revenue, applications, Medicare tail revenue, Medicare gross profit, segment economics and cash balances, alongside ongoing preferred equity capital structure discussions. The positive operational and strategic developments were offset by the magnitude of the current financial declines, resulting in a balanced outlook.
Management reaffirmed its fiscal year 2026 guidance ranges, including full-year operating cash flow at “breakeven or better,” 2026 net adjustment revenue in the range of $17 million to $20 million, total 2026 cost savings of more than $60 million, fixed cost savings of approximately $30 million, and a reduction in 2026 variable and fixed operating costs and expenses by approximately $90 million compared with 2025; fourth quarter operating cash flow is currently expected to also show a meaningful improvement compared to Q4 of '25, while the company’s longer-term objectives include returning to mid-single-digit revenue growth in 2027, accompanied by expanded adjusted EBITDA margins and positive operating cash flow.
- Improved Year-to-Date Operating Cash FlowOperating cash flow increased to $19.6 million for the first 9 months of 2026 from $10.6 million in the same period a year ago, which management described as nearly doubling and an 85% year-over-year improvement. The company expects fourth quarter operating cash flow to show a meaningful improvement compared with Q4 2025 and remains on track for breakeven or better operating cash flow for the full year.
- Significant Cost Reduction ProgressThe company is on target to reduce 2026 variable and fixed operating costs and expenses by approximately $90 million compared with 2025. It is also tracking toward more than $60 million of total 2026 cost savings and approximately $30 million of fixed cost savings. Combined general and administrative and technology and content expenses declined 17%, total marketing and advertising expense declined 55%, customer care and enrollment expense declined 22%, and total operating costs and expenses declined 29% year over year.
- Strong Early AEP Demand and Favorable Lead CostsDuring the first 3 weeks of the annual enrollment period, management reported strong consumer demand at attractive lead costs across the platform. Early cost per call and cost per visit were favorable, while branded channels were expected to drive the majority of fourth-quarter AEP applications, similar to last year.
- Lifetime Advisory Model Shows Early Retention and Cross-Sell BenefitsThe ancillary cross-sell rate exceeded 40% in the third quarter, nearly doubling year over year. Policies enrolled in the second quarter by career advisers following the model's launch experienced lower churn during the first 90 days than in the same period last year, and the January 2026 effective policy cohort was showing stronger year-to-date retention than the comparable prior-year cohort despite significant Medicare Advantage plan changes.
- Improved Medicare Marketing EfficiencyThe ratio of third-quarter Medicare segment revenue to Medicare variable marketing and advertising costs increased to 3.9x from 2.9x. Management said it is concentrating marketing investment in primary enrollment periods when consumer demand and expected returns are highest.
- Carrier Relationships and Amplify DemandCarriers have communicated targeted growth mandates for specific plan types and geographies, and the company is seeing increased interest in its carrier-dedicated Amplify business. Management said the early performance could create opportunities to grow that business in 2027 and beyond.
- New BPO Agreement with a Top Three Medicare CarrierThe company signed a new BPO agreement with a top 3 Medicare carrier to provide carrier-branded enrollment support during AEP. Management expects the BPO relationship and sponsorship revenue to begin contributing revenue in the fourth quarter.
- Medicare Market Stabilization SignalsManagement said carriers are operating in a more predictable environment, medical loss ratios for certain key carriers have begun to improve based on year-to-date earnings reports, and sponsorship revenue is gradually returning during the current AEP. The company believes the Medicare Advantage market could begin shifting toward a disciplined growth environment in 2027.
- Content Genius AI Platform LaunchThe company launched Content Genius, an AI-powered platform for gathering, validating and publishing information on thousands of Medicare Advantage plans. Management said it has significantly improved content loading speed with comparable accuracy while reducing the cost of content processing, which had previously been labor-intensive ahead of each AEP.
- ICHRA/CHOICE Diversification OpportunityA recent eHealth survey found that 54% of small and midsized businesses offering group coverage face premium increases of 10% or more for 2027, 73% are considering discontinuing traditional health benefits in 2027, and 58% are pursuing alternatives such as level-funded or self-funded plans or ICHRA arrangements. Management believes greater employer awareness of the newly branded CHOICE model can support broader adoption over time.
- BerniePortal Partnership Expands CHOICE DistributionThrough its partnership with BerniePortal, more than 5,000 employers and 1,000 insurance brokers working with the platform are expected to gain access to eHealth for needs analysis and support evaluating CHOICE arrangement options. The partnership includes PMPM administration revenue per employee and broker commission.
- Reaffirmed 2026 Guidance and 2027 Financial ObjectivesThe company reaffirmed its fiscal year 2026 guidance ranges and updated expected 2026 net adjustment revenue to $17 million to $20 million from $16 million to $20 million, reflecting $1.4 million of third-quarter tail revenue. Longer term, management continues to target a return to mid-single-digit revenue growth in 2027, expanded adjusted EBITDA margins and positive operating cash flow.
- Liquidity and Receivables Support Operating PlansManagement said liquidity, the significant commissions receivable balance and the improving cash flow profile provide a solid foundation for executing operating and strategic priorities. Commissions receivable totaled $970.6 million as of September 30, compared with $907.7 million a year earlier.
DE:M5V Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | 2.49- | 2.31 | ― | ― |
| Nov 04, 2026 | 2026 (Q3) | -0.98-1.30 | -1.13 | -15.03% (-0.17) | |
| Aug 04, 2026 | 2026 (Q2) | -0.75-0.99 | -1.12 | 12.02% (+0.14) | |
| May 06, 2026 | 2026 (Q1) | -0.18-0.27 | -0.42 | 35.39% (+0.15) | |
| Feb 25, 2026 | 2025 (Q4) | 2.582.31 | 2.83 | -18.29% (-0.52) | |
| Nov 05, 2025 | 2025 (Q3) | -0.99-1.13 | -1.18 | 4.10% (+0.05) | |
| Aug 06, 2025 | 2025 (Q2) | -1.09-1.12 | -1.24 | 9.64% (+0.12) | |
| May 07, 2025 | 2025 (Q1) | -0.47-0.42 | -0.73 | 42.45% (+0.31) | |
| Feb 26, 2025 | 2024 (Q4) | 2.202.83 | 1.3 | 117.03% (+1.53) | |
| Nov 06, 2024 | 2024 (Q3) | -1.23-1.18 | -1.05 | -12.36% (-0.13) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.


